Volcanic ash fallout hits pharma
April 21, 2010Manufacturing and Production Clinical Supply Operations, disaster, logistics, supply chain
The headline news in the wake of the Icelandic volcano eruption has been of stranded passengers struggling to get home …
Secondary endpoints failure take shine off Benlysta
April 21, 2010Sales and Marketing GSK, HGS, Lupus
GlaxoSmithKline’s lupus treatment has failed to reach a statistically significant secondary endpoint in the second of two phase III trials. …
Wyeth’s Ursula Franklin joins Red Kite
April 21, 2010Business Services, Sales and Marketing Red Kite, appointment, coaching, development, leadership, sales and marketing, strategic planning, strategy, training
Red Kite has appointed Ursula Franklin to head up its new Transformation division. She joins from Wyeth Europa, now part …
GSK’s Arzerra conditionally approved in Europe
April 20, 2010Research and Development, Sales and Marketing Arzerra, GSK, leukaemia
GlaxoSmithKline’s orphan cancer treatment Arzerra has been given conditional marketing authorisation in the European Union. Arzerra (ofatumumab) can be used …
Oracle buys eClinical specialist Phase Forward for $685m
April 20, 2010Research and Development Covance, Oracle, Phase Forward
Business software giant Oracle has taken a leap forward in the healthcare arena with a $685 million cash offer to …
Emerging markets and generics poised to drive pharma growth
April 20, 2010Sales and Marketing IMS, em, emerging markets
The global pharma market will reach $1.1 trillion in 2014 through growth primarily driven by emerging markets and generics, according …
Lilly faces substantial costs from US health reform
April 20, 2010Sales and Marketing 2010 financials, Obama, lilly
Lilly expects to lose up to $485 million this year as a direct result of the US healthcare reforms, but …
ABPI appoints Roche’s Paul Catchpole
April 20, 2010Sales and Marketing ABPI, UK, appointment, sales and marketing
UK industry association the ABPI has appointed Paul Catchpole as director of value and access. He will join the association …
Third Apotex plant cited in FDA warning letter
April 19, 2010Manufacturing and Production Apotex, generics, manufacturing compliance
Canada’s Apotex has been sent a warning letter citing manufacturing violations at a facility in Toronto that are identical to …
Trial boost for Merck KGaA’s cladribine
April 19, 2010Research and Development Cladribine, MS, Merck KGaA, Merck Serono
New data from German pharma company Merck suggests its oral multiple sclerosis treatment cladribine has been successful in treating relapsing …
Novartis set to boost generic portfolio
April 19, 2010Sales and Marketing Novartis, Sandoz, generics
Novartis’ generics arm Sandoz has signed a deal to acquire US-based inhalable drug specialist Oriel Therapeutics. Sandoz will gain rights …
MedImmune: building a biologics future
April 19, 2010Research and Development MedImmune, biologics
I paid my visit to MedImmune’s UK headquarters in Cambridge only days after its parent company AstraZeneca announced the closure …
Action Pharma appoints new chief executive
April 19, 2010Research and Development Action Pharma, appointment, research and development
Ingelise Saunders has joined Danish biotech Action Pharma as its new chief executive. She will be involved in seeking partners …
Lane Earl Cox wins allergy blood test account
April 16, 2010Medical Communications LEC, Phadia, allergy
Healthcare advertising agency Lane Earl & Cox has won the account to promote an allergy blood test product from diagnostics …
Genzyme appoint investor to outmanoeuvre Icahn
April 16, 2010Sales and Marketing Contamination, Genzyme
Genzyme has appointed the head of one of its biggest shareholders to its board in order to block a hostile …
Pharma manufacturing news in brief
April 16, 2010Manufacturing and Production
A round-up of news in the pharmaceutical manufacturing arena includes the removal of CFC-based MDIs from the US market, facility …
Emerging markets lift Roche in Q1
April 16, 2010Sales and Marketing Roche, emerging markets
Roche saw its sales grow 9% overall in the first quarter, with emerging markets medicines revenues showing a healthy 38% …
Maike Fieber joins Photosound
April 16, 2010Medical Communications Photosound, appointment, medical communications
Photosound has appointed Maike Fieber as an account manager.She joins the agency from Ogilvy & Mather in Dusseldorf, where she …
Cephalon completes acquisition of generics firm Mepha
April 16, 2010Sales and Marketing Cephalon, generics
Specialist pharmaceutical company Cephalon has completed the $615.4 million acquisition of Mepha. Based in Switzerland, Mepha specialises in using reformulation …
Digital Pharma: Online ‘keepy uppies’ from Bayer
April 15, 2010Medical Communications Bayer Schering Pharma, Langland, digi game, digital pharma, disease awareness campaigns, haemophilia, iphone
Bayer Schering Pharma is counting down to World Haemophilia Day with a football-themed online disease awareness campaign. The centre-piece of …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
